Renal cell carcinoma: Difference between revisions

Jump to navigation Jump to search
Line 52: Line 52:


==Diagnosis==
==Diagnosis==
Most patients are diagnosed with renal cell carcinoma following the incidental finding of the tumor during abdominal radiological work-up. The most common symptom associated with the disease is hematuria. Physical exam may be unrevealing, or may be positive for signs of local tumor extension, paraneoplastic syndromes, or metastases, such as a palpable abdominal mass, high blood pressure, facial flushing, skin pallor, or other neurological, pulmonary, or musculoskeletal abnormalities. Common laboratory findings may show anemia or polycythemia, hypercalcemia, elevated serum creatinine, elevated liver function tests, ESR, ALP, and LDH. Imaging is an important diagnostic and follow-up procedure in renal cell carcinoma. The use of CT, MRI, CXR, and ultrasound are all feasible options in the work-up, according to the 2013 American Urological Association (AUA) guidelines.<br><br>
Most patients are diagnosed with renal cell carcinoma following the incidental finding of the tumor during abdominal radiological work-up. The gold standard of diagnosis is percutaneous needle biopsy of the involved kidney, with or without imaging-guidance. The most common symptom associated with the disease is hematuria. Physical exam may be unrevealing, or may be positive for signs of local tumor extension, paraneoplastic syndromes, or metastases, such as a palpable abdominal mass, high blood pressure, facial flushing, skin pallor, or other neurological, pulmonary, or musculoskeletal abnormalities. Common laboratory findings may show anemia or polycythemia, hypercalcemia, elevated serum creatinine, elevated liver function tests, ESR, ALP, and LDH. Imaging is an important diagnostic and follow-up procedure in renal cell carcinoma. The use of CT, MRI, CXR, and ultrasound are all feasible options in the work-up, according to the 2013 American Urological Association (AUA) guidelines.<br><br>
[[Renal cell carcinoma staging|Staging]] | [[Renal cell carcinoma history and symptoms|History and Symptoms]] | [[Renal cell carcinoma physical examination|Physical Examination]] | [[Renal cell carcinoma laboratory findings|Laboratory Findings]] | [[Renal cell carcinoma CT|CT]] | [[Renal cell carcinoma MRI | MRI]] | [[Renal cell carcinoma echocardiography or ultrasound| Ultrasound]] | [[Renal cell carcinoma other imaging findings|Other Imaging Findings]] | [[Renal cell carcinoma other diagnostic studies|Other Diagnostic Studies]]
[[Renal cell carcinoma staging|Staging]] | [[Renal cell carcinoma history and symptoms|History and Symptoms]] | [[Renal cell carcinoma physical examination|Physical Examination]] | [[Renal cell carcinoma laboratory findings|Laboratory Findings]] | [[Renal cell carcinoma CT|CT]] | [[Renal cell carcinoma MRI | MRI]] | [[Renal cell carcinoma echocardiography or ultrasound| Ultrasound]] | [[Renal cell carcinoma other imaging findings|Other Imaging Findings]] | [[Renal cell carcinoma other diagnostic studies|Other Diagnostic Studies]]



Revision as of 19:33, 12 January 2014

For patient information click here

Template:DiseaseDisorder infobox

Renal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal cell carcinoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma

CDC on Renal cell carcinoma

Renal cell carcinoma in the news

Blogs on Renal cell carcinoma

Directions to Hospitals Treating Renal cell carcinoma

Risk calculators and risk factors for Renal cell carcinoma

Steven C. Campbell, M.D., Ph.D.

Contributors: C. Michael Gibson, M.S., M.D., Cafer Zorkun M.D., PhD. Michael Maddaleni, B.S.

Synonyms and key Words: RCC, renal cell CA, kidney cancer, kidney carcinoma, kidney CA, Grawitz tumor, hypernephroma

Overview

Historical Perspective

Renal cell carcinoma was first described in 1826. Following contradictory hypotheses regarding the origin of renal tumors, it was not until 1960 that Oberling and colleagues showed that renal carcinomas originate from renal cells.

Classification

Classification of renal cell carcinomas according to histopathological subtypes is based on the 1997 classification by Heidelberg and colleagues. Classification may also be according to the stage of renal cell carcinoma, which often is based on Robson classification system or the tumor-lymph node-metastasis (TNM) system.

Pathophysiology

The pathophysiology of renal cell carcinomas plays an important role in differentiating different types of renal cell carcinomas and in choosing appropriate targeted medical therapies. Sporadic forms of clear cell renal carcinomas, the most common form of renal cell carcinomas, have similar pathophysiological mechanisms to those of von Hippel Lindau (VHL) disease. On the other hand, MET proto-oncogene seems to play a role in the disease pathogenesis of papillary forms of renal cell carcinoma. Uniquely also, oncocytomas are benign tumors that arise from type A intercalated cells, whereas chromophobe renal cell carcinoma arises from type B intercalated cells.

Causes

Most renal cell carcinomas develop sporadically. Only a few have genetic predisposition and are associated with known syndromes, such as von Hippel Lindau (VHL), hereditary paragangliomas, leiomyomatosis, and Birt-Hogg-Dube (BHD) syndrome, among several others.

Differentiating Renal cell carcinoma from other Diseases

The differential diagnosis of renal cell carcinomas includes metastastic disease, cysts, abscesses, lymphomas, and other benign and malignant tumors, and associated syndromes.

Epidemiology and Demographics

Renal cell carcinoma is considered the 7th most common cancer in men and 9th most common cancer in women, accounting for approximately 2-3% of malignant tumors in adults. Men are twice more likely to be affected than women with an mean age of presentation at 60 years. Most renal cell carcinomas develop sporadically, while only a small number of cases are of genetic diseases. Clear cell carcinomas are the most common renal cell carcinomas and collecting-duct carcinomas are the least common. Renal cell carcinomas are mostly found incidentally during radiological abdominal work-up.

Risk Factors

Established risk factors for renal cell carcinoma include cigarette smoking, hypertension, end-stage renal failure, analgesic drug use, environmental exposure to carcinogens, and some genetic syndromes.

Screening

There are currently no guidelines for screening for renal cell carcinoma.

Natural History, Complications and Prognosis

The projected 5-year survival is significantly associated with the stage of the tumor at diagnosis. Stage I tumors are associated with more than 90% 5-year survival vs. less than 20% survival for tumors of stage IV. The potential aggression of a tumor has been shown to be associated with tumor size, grade of tumor, and histopathological subtype. High grade tumors greater than 7 cm of clear cell type generally have a higher aggressive potential than low grade tumors smaller than 3 cm of papillary type. Finally, complications vary according to the local extension of the tumor, and the presence of paraneoplastic syndromes and/or metastases.

Diagnosis

Most patients are diagnosed with renal cell carcinoma following the incidental finding of the tumor during abdominal radiological work-up. The gold standard of diagnosis is percutaneous needle biopsy of the involved kidney, with or without imaging-guidance. The most common symptom associated with the disease is hematuria. Physical exam may be unrevealing, or may be positive for signs of local tumor extension, paraneoplastic syndromes, or metastases, such as a palpable abdominal mass, high blood pressure, facial flushing, skin pallor, or other neurological, pulmonary, or musculoskeletal abnormalities. Common laboratory findings may show anemia or polycythemia, hypercalcemia, elevated serum creatinine, elevated liver function tests, ESR, ALP, and LDH. Imaging is an important diagnostic and follow-up procedure in renal cell carcinoma. The use of CT, MRI, CXR, and ultrasound are all feasible options in the work-up, according to the 2013 American Urological Association (AUA) guidelines.

Staging | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

Template:Tumors Template:Nephrology Template:Tumor morphology

bs:Rak bubrega de:Nierenkrebs hr:Rak bubrega it:Cancro del rene fi:Munuaissyöpä sv:Njurcancer


Template:WikiDoc Sources